Novartis articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/10/25 15:09
2014/10/25 15:09
6h
Drugmaker Bristol-Myers Squibb Co. beat analysts' earnings estimates on better-than-expected sales of several key medicines led by the cancer therapy Yervoy. Third-quarter net income rose 4.2 percent...
2014/10/25 15:09
2014/10/25 15:09
Latest videos
2014/10/24 23:27
2014/10/24 23:27
21h
According to Thomson Reuters, 70 percent of the S&P 500 companies reporting so far have beaten earnings estimates, while 59 percent have beaten on revenues. The materials, financials, health care, and...
2014/10/24 19:43
2014/10/24 19:43
1d
All life-saving medicines for critical diseases, such as anti-retrovirals, anti-tuberculosis, pediatric formulations and fixed-dose combinations, might soon come under the government's price control....
2014/10/24 15:17
2014/10/24 15:17
1d
Despite world-wide economic downturn and great changes in exchange rate, benefiting from robust market demand, global monoclonal antibody market size exceeded USD 80 billion in 2013, still one of...
2014/10/24 13:42
2014/10/24 13:42
1d
Dr. Peter B. Bach is a physician at Memorial Sloan Kettering Cancer Center and the Director of its Center for Health Policy and Outcomes. He is a passionate advocate for patients and often eloquently...
2014/10/24 06:42
2014/10/24 06:42
1d
Paul Herrling is the chairman of the board of the Singapore-based Novartis Institute for Tropical Disease. He has held various positions at Novartis and Sandoz since 1975, including head of research...
2014/10/23 20:59
2014/10/23 20:59
2d
On October 20th, iPhone 6 or 6 Plus users with Visa cards issued by Bank of America, Capital One, Citi Bank, Chase and Wells Fargo Bank began to be able to initiate mobile purchases with Apple Pay in...
2014/10/23 15:43
2014/10/23 15:43
2d
Director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center Policymakers are scrutinizing high prices for specialty drugs like never before. Gilead’s Sovaldi at $84,000...
2014/10/23 10:19
2014/10/23 10:19
2d
Net income per share, as adjusted1, of $0.67 (diluted) for the quarter ended September 30, 2014, compared to $0.46 for the 2013 third quarter Record third-quarter operating revenue1 of $583 million,...
2014/10/23 06:27
2014/10/23 06:27
2d
GlaxoSmithKline (GSK), reported third-quarter revenue down 3 percent to £5.6 billion ($8.9 billion), lower than the £5.7 billion forecast by analysts, as sales of its blockbuster asthma drug Advair...
Read more at CNBC, + 4 more articles
2014/10/23 04:55
2014/10/23 04:55
2d
The Osmond family is world-renowned for its show business legacy. But for one Osmond, following in the footsteps of his family meant overcoming a personal struggle with a lifelong condition – multiple...
2014/10/22 15:46
2014/10/22 15:46
3d
... The number of companies lobbying the U.S. government on tax inversions more than doubled in the quarter ending Sept. 30, as they sought to prevent Congress and the Obama administration...
2014/10/22 14:34
2014/10/22 14:34
3d
In 2005, during the parliamentary debate on the Patents Amendment Bill, Bharatiya Janata Party leader V.K. Malhotra stated, “The government will be now responsible for the consequences of the bill and...
2014/10/22 12:13
2014/10/22 12:13
3d
Brentford-based GSK saw turnover slump 14% to £16.8 billion in the first nine months of the year, and operating profit was down 37% to £2.9 billion. As chief executive Sir Andrew Witty set out plans...
2014/10/22 11:27
2014/10/22 11:27
3d
Oct. 22 (Bloomberg) -- Roche Holding AG plans to invest 3 billion Swiss francs ($3.2 billion) at its Basel headquarters over the next decade as the world’s biggest maker of cancer drugs updates its...
2014/10/22 07:07
2014/10/22 07:07
3d
In his final hours, Christophe de Margerie was doing what was expected of any modern chief executive officer: representing his company in the globe’s farthest-flung destinations. The CEO of French...
2014/10/22 01:36
2014/10/22 01:36
3d
Treatment was started immediately after randomisation, was given daily for 7 days, and consisted of a glyceryl trinitrate dermal patch (5 mg) or no patch. Glyceryl trinitrate patches were sourced...
2014/10/21 13:42
2014/10/21 13:42
4d
More exciting news has emerged from the immuno-oncology field over the past couple weeks from both Penn/Novartis and NCI/Kite. The former released new CAR-T data, widely heralded as “unprecedented” in...
2014/10/20 15:31
2014/10/20 15:31
5d
Oct. 20 (Bloomberg) -- Molecular Partners AG, a Swiss biotechnology company holding an initial public offering this week, plans to challenge Roche Holding AG and Novartis AG in a $6 billion eye-drug...
2014/10/20 10:36
2014/10/20 10:36
5d
On July 22, 2014, “An open letter for the people of Gaza”, by Paola Manduca and coauthors, was published online by The Lancet, subsequently appearing in the journal's issue of Aug 2.1 Accompanying the...
2014/10/25 15:09
2014/10/25 15:09
Latest from Twitter